SPHK1 and ischemic stroke: However, the SphK inhibitor, DMS, increases the number of autophagosomes with a corresponding reduction in the expression of the main autophagy substrate, p62, which implies that the S1P/SphK pathway is involved in the process of autophagic activation following ischemic stroke.